- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02296619
The Effects of Transversus Abdominis Plane Block in Patients Undergoing Total Abdominal Hysterectomy (TAP)
February 25, 2016 updated by: Tuğba Karaman, Tokat Gaziosmanpasa University
The Effects of TAP Block on Hemodynamic Variables, Anaesthetic and Analgesic Requirement and Quality of Recovery in Patients Undergoing Total Abdominal Hysterectomy
The purpose of this study is to determine the effects of Transversus Abdominis Plane Block on hemodynamic variables, anaesthetic and analgesic requirement, and quality of recovery in patients undergoing total abdominal hysterectomy
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Pain is one of the main causes of the poor perioperative outcomes and pain management is the important part of perioperative period.
Neuraxial blocks could provide adequate analgesia during and after abdominal surgery.
However,neuraxial blocks have a lot of contraindicated situations and neuraxial anesthesia can easily induce hemodynamic abnormalities.
Therefore, in most cases, the choice of anaesthetic management may be the general anesthesia.
In addition to reduce the blood pressure and heart rate changes due to surgical stimulations, the large amount of opioids and anaesthetics may be required.
Opioid related side effects can affect perioperative complications and postoperative quality of recovery.
Transversus abdominis plane block is a new choice to reduce postoperative pain in abdominal surgery.
Although its postoperative analgesic efficacy is well known, its effects on hemodynamic variables, anaesthetic and analgesic requirement is not clear.
The main objective of this study is to estimate the effect of Transversus abdominis plane block on hemodynamic variables, anaesthetic and analgesic requirement and quality of recovery in patients undergoing total abdominal hysterectomy.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Merkez
-
Tokat, Merkez, Turkey, 60100
- Gaziosmanpasa University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Adult (18-65years old)
- American Society of Anesthesiologists (ASA) physical status I-II
- Patients scheduled for elective total abdominal hysterectomy under general anesthesia
Exclusion Criteria:
- ASA physical status ≥ 3
- Allergy to local anesthetics
- Drug abuse or addiction
- Bleeding tendency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TAP Block
Using real time ultrasound imaging, bilateral, 20 ml 0,25% bupivacaine inject into the area between the internal oblique and transverse abdominis muscle
|
Using real time ultrasound imaging, bilateral, 20 ml 0,25% bupivacaine inject into the area between the internal oblique and transverse abdominis muscle
Other Names:
|
Sham Comparator: Control
A sham band-aid will be applied to the abdomen of subjects who are randomized to the no intervention group.
|
A sham band-aid will be applied to the abdomen of subjects
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
intraoperative opioid consumption
Time Frame: during anaesthesia
|
The overall intravenous remifentanyl consumption (microgram/ kilogram) during the surgery.
The decision to administer remifentanyl is guided by the changes of blood pressure and/ or heart rate greater than 20% from baseline level.
|
during anaesthesia
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of recovery
Time Frame: postoperative 24 hours
|
quality of recovery 40 form will use to assessment the recovery
|
postoperative 24 hours
|
Postoperative nausea and vomiting
Time Frame: postoperative 0.,2.,12.,24 hours
|
nausea score(0-3) and number of vomiting will be recorded
|
postoperative 0.,2.,12.,24 hours
|
postoperative pain
Time Frame: postoperative 0,2,12,24 hours
|
visual analog scale will be used
|
postoperative 0,2,12,24 hours
|
intraoperative hemodynamic variables
Time Frame: during anaesthesia
|
arterial blood pressure, heart rate changes will be recorded
|
during anaesthesia
|
intraoperative anaesthetic consumption
Time Frame: during anaesthesia
|
anaesthetic consumption will be calculated
|
during anaesthesia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tuğba Karaman, MD, GOU
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
February 1, 2016
Study Registration Dates
First Submitted
November 13, 2014
First Submitted That Met QC Criteria
November 18, 2014
First Posted (Estimate)
November 20, 2014
Study Record Updates
Last Update Posted (Estimate)
February 26, 2016
Last Update Submitted That Met QC Criteria
February 25, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GaziosmanpashaU
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraoperative Complications
-
West China Second University HospitalCompleted
-
Catholic University of the Sacred HeartCompletedIntraoperative AwarenessItaly
-
Universiti Sains MalaysiaCompleted
-
Rajiv Gandhi Cancer Institute & Research Center...Unknown
-
Assiut UniversityCompletedIntraoperative AwarenessEgypt
-
King's College Hospital NHS TrustUnknownPostoperative Complications | Intraoperative Complications | Complication | Intraoperative Neurophysiological MonitoringUnited Kingdom
-
University Hospital Hradec KraloveRecruitingAnesthesia AwarenessCzechia
-
University of PennsylvaniaSuspended
-
University of Wisconsin, MadisonRambam Health Care Campus; University of Pennsylvania; RWTH Aachen University; Ludwig-Maximilians... and other collaboratorsCompletedAnesthesia AwarenessUnited States, New Zealand, Israel, Belgium, Germany, Australia, Netherlands
-
University of PadovaCompleted
Clinical Trials on TAP block
-
Ankara City Hospital BilkentCompletedPostoperative Pain, Acute | Analgesia, Patient-ControlledTurkey
-
Aga Khan UniversityCompletedSubcostal TAP Block for Multiport Laparoscopic Cholecystectomy
-
Spectrum Health HospitalsCompletedPostoperative PainUnited States
-
Liverpool University Hospitals NHS Foundation TrustCompletedPain | Disorder Related to Renal TransplantationUnited Kingdom
-
Vittore Buzzi Children's HospitalRecruiting
-
Indiana UniversityHalyard HealthCompleted
-
University of AlbertaTerminated
-
Biruni UniversityCompleted
-
University of California, San FranciscoWithdrawnTransplantation, KidneyUnited States